HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia

Antioxidants and Redox Signaling

Volumn 9, Issue 9, 2007, Pages 1391-1396

  Semenza, Gregg L ^a   Prabhakar, Nanduri R ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATECHOLAMINE DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; OXYGEN; REACTIVE OXYGEN METABOLITE;

ADRENERGIC SYSTEM; ALLELE; APNEA; CARDIOVASCULAR SYSTEM; CAROTID BODY; CHRONIC INTERMITTENT HYPOXIA; EXPOSURE; GENE EXPRESSION; GENE LOCUS; HETEROZYGOSITY; HIGH RISK POPULATION; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPOXIA; MORBIDITY; MORTALITY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; WILD TYPE;

ANOXIA; CARDIOVASCULAR SYSTEM; CHRONIC DISEASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXIDATION-REDUCTION; RESPIRATORY SYSTEM; SLEEP APNEA SYNDROMES;

MUS; RODENTIA;

EID: 34547883937     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1691     Document Type: Review

References (52)

1. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, Liu E, Sergueeva AI, Miasnikova GY, Mole D, Maxwell PH, Stockton DW, Semenza GL, and Prchal JT. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32: 614-621, 2002.
2. Baker TL and Mitchell GS. Episodic but not continuous hypoxia elicits long-term facilitation of phrenic motor output in rats. J Physiol 529: 215-219, 2000.
3. Bruick RK and McKnight, SL. Transcription: oxygen sensing gets a second wind. Science 295: 807-808, 2002.
4. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, and Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103: 1763-1768, 1993.
5. Compernolle V, Brusselmans K, Franco D, Moorman A, Dewerchin M, Collen D, and Carmeliet P. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1α. Cardiovasc Res 60: 569-579, 2003.
6. Czyzyk-Krzeska MF, Furnari BA, Lawson EE, and Millhorn DE. Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells. J Biol Chem 269: 760-764, 1994.
7. Czyzyk-Krzeska MF, Schnell PO, Bauer AL, Striet JB, Nash JA, Kuznetsova AV, and Hui AS. Regulation of tyrosine hydroxylase gene expression by hypoxia in neuroendocrine cells. In: Oxygen Sensing: Responses and Adaptation to Hypoxia, edited by Lahiri S, Semenza GL, and Prabhakar NR. New York: Marcel Dekker, 2003, pp. 153-174.
8. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, and Gleadle JM. Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1α, HIF-2α, and other pathways. J Biol Chem 281: 15215-15226, 2006.
9. Fletcher EC, Lesske J, Qian W, Miller CC 3rd, and Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19: 555-561, 1992.
10. Fletcher EC, Lesske J, Behm R, Miller CC 3rd, Stauss H, and Unger T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol 72: 1978-1984, 1992.
11. Fletcher EC, Lesske J, Culman J, Miller CC, and Unger T. Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 20: 612-619, 1992.
12. Fletcher EC, Miller J, Schaaf JW, and Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10: 35-44, 1987.
13. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, and Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996.
14. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, and Semenza GL. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277: 38205-38211, 2002.
15. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, and Schumacker PT. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1: 401-408, 2005.
16. Hedner J, Ejnell H, Sellgren J, Hedner T, and Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl 6: S529-S531, 1988.
17. Hirota K and Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 59: 15-26, 2006.
18. Hui AS, Bauer AL, Striet JB, Schnell PO, and Czyzyk-Krzeska MF. Calcium signaling stimulates translation of HIF-α during hypoxia. FASEB J 20:466-475, 2006.
19. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev12: 149-162, 1998.
20. Kietzmann T and Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 16: 474-486, 2005.
21. Kline DD, Peng YJ, Manalo DJ, Semenza GL, and Prabhakar NR. Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. Proc Natl Acad Sci U S A 99: 821-826, 2002.
22. Kumar GK, Overholt JL, Bright GR, Hui KY, Lu H, Gratzl M, and Prabhakar NR. Release of dopamine and norepinephrine by hypoxia from PC-12 cells. Am J Physiol 274: C1592-C1600, 1998.
23. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Souvannakitti D, and Prabhakar NR. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575: 229-239, 2006.
24. Laughner E, Taghavi P, Chiles K, Mahon PC, and Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21: 3995-4004, 2001.
25. Li J, Bosch-Marce M, Nanayakkara A, Savransky V, Fried SK, Semenza GL, and Polotsky VY. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1α. Physiol Genomics 25: 450-457, 2006.
26. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, and Semenza GL. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669, 2005.
27. Maxwell PH and Ratcliffe PJ. Regulation of HIF-1 by oxygen: the role of prolyl hydroxylase and the VHL tumor suppressor. In: Oxygen sensing: responses and adaptation to hypoxia, edited by Lahiri S, Semenza GL, and Prabhakar NR. New York: Marcel Dekker, 2003, pp. 47-65.
28. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, and Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283: 1829-1836, 2000.
29. Peet DJ, Lando D, Whelan DA, Whitelaw ML, and Gorman JJ. Oxygen-dependent asparagine hydroxylation. Methods Enzymol 381: 467-487, 2004.
30. Peng YJ, Overholt JL, Kline D, Kumar GK, and Prabhakar NR. Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc Natl Acad Sci USA 100: 10073-10078, 2003.
31. Peng YJ and Prabhakar NR. Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity. J Appl Physiol 96: 1236-1242, 2004.
32. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, and Prabhakar NR. Heterozygous HIF-1α deficiency impairs carotid body-mediated cardio-respiratory responses and reactive oxygen species generation in mice exposed to chronic intermittent hypoxia. J Physiol 577: 705-716, 2006.
33. Prabhakar NR, Kumar GK, Nanduri J, Semenza GL. ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid Redox Signal 9: 1397-1403.
34. Ramanathan L, Gozal D, and Siegel JM. Antioxidant responses to chronic hypoxia in the rat cerebellum and pons. J Neurochem 93: 47-52, 2005.
35. Reeves SR and Gozal D. Changes in ventilatory adaptations associated with long-term intermittent hypoxia across the age spectrum in the rat. Respir Physiol Neurobiol 150: 135-143, 2006.
36. Report of the National Commission on Sleep Disorders Research. Volume Two: Working Group Reports. U. S. Government Printing Office, 1995.
37. Ryan HE, Lo J, and Johnson RS. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 17: 3005-3015, 1998.
38. Semenza GL and Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12: 5447-5454, 1992.
39. Shimoda LA, Fallon M, Pisarcik S, Wang J, and Semenza GL. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am J Physiol 291: L941-L949, 2006.
40. Shimoda LA, Manalo DJ, Sham JS, Semenza GL, and Sylvester JT. Partial HIF-1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol 281: L202-L208, 2001.
41. Smith TG, Brooks JT, Balanos GM, Lappin TR, Layton DM, Leedham DL, Liu C, Maxwell PH, McMullin MF, McNamara CJ, Percy MJ, Pugh CW, Ratcliffe PJ, Talbot NP, Treacy M, and Robbins PA. Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med 3: e290, 2006.
42. Somers VK, Dyken ME, Clary MP, and Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96: 1897-1904, 1995.
43. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, and Van Obberghen E. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277: 27975-27981, 2002.
44. 2 tension. Proc Natl Acad Sci U S A 92: 5510-5514, 1995.
45. Wang GL and Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237, 1995.
46. 2+ in pulmonary arterial smooth muscle cells. Circ Res 98: 1528-1537, 2006.
47. Yang H, Ivan M, Min J, Kim WY, and Kaelin WG Jr. Analysis of von Hippel-Lindau hereditary cancer syndrome: implications of oxygen sensing. Methods Enzymol 381: 320-335, 2004.
48. Yoon D, Pastore YD, Divoky V, Liu E, Mlodnicka AE, Rainey K, Ponka P, Semenza GL, Schumacher A, and Prchal JT. Hypoxia-inducible factor 1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem 281: 25703-25711, 2006.
49. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, and Skatrud J. Arch Intern Med 157: 1746-1752, 1997.
50. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, and Semenza GL. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J Clin Invest 103: 691-696, 1999.
51. Yuan G, Adhikary G, McCormick AA, Holcroft JJ, Kumar GK, and Prabhakar NR. Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells. J Physiol 557: 773-783, 2004.
52. 2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 280: 4321-4328, 2005.